Back to Agenda
Session 2: 21st Century Cures and PDUFA: Combination Products Implications
Session Chair(s)
Carla Cartwright, JD, LLM
Director, Federal Affairs
Johnson & Johnson, United States
Learning Objective :
Speaker(s)
21st Century Cures from Three Sides: Hill, Agency, and Industry Perspectives
Kalah Auchincloss
Greenleaf Health, Inc., United States
Senior Vice President, Regulatory Compliance
Speaker
Cartier Esham, PhD, MSc
Biotechnology Innovation Organization (BIO), United States
Chief Scientific Officer
![Grace Stuntz](/_Images/member/Generic_Image_Missing-Profile.jpg)
Speaker
Grace Stuntz
Senate HELP Committee, Republican Staff, United States
FDA Policy Advisor
Speaker
Remy Brim
FDA, United States
Have an account?